Finance entity
Every one of those 1 sits in a single category, markets. Charles River Laboratories International, Inc. is most often covered alongside U.S. Securities and Exchange Commission, which appears in 1 of these 1 story. Source depth averages 2 original sources per story, versus 2.2 across the same-window beat baseline.
Last mentioned: Aug 13, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
Every one of those 1 sits in a single category, markets. Charles River Laboratories International, Inc. is most often covered alongside U.S. Securities and Exchange Commission, which appears in 1 of these 1 story. Source depth averages 2 original sources per story, versus 2.2 across the same-window beat baseline. At 5, the average consequence score sits below the same-window beat average of 5.5. We currently track 1 Finance story that mention Charles River Laboratories International, Inc., all published on August 13, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 41 Finance stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Charles River Laboratories International, Inc.. Shared-story counts are live from our verified record — not editorial picks.
Charles River Laboratories EVP Victoria Creamer sold 4,179 shares for $1.08 million just one day after the CRO beat Q2 estimates. We break down the SEC filing, earnings context, and what the insider sale signals for CRL investors.
Source: tickerreport.com · dailypolitical.com
Charles River Laboratories International, Inc. is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
